Abbott Laboratories
ABL.DE
Get informed when a big investor buys or sells
+ FollowMarket Cap$168.71B
Close$
Share Statistics
| Market cap | $168.71 Billion |
|---|---|
| Enterprise Value | $196.63 Billion |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 10.61% |
|---|---|
| Return on Assets | 4.97% |
| Return on Invested Capital | 8.70% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 4.22 |
| Enterprise Value to EBIT | 24.73 |
| Enterprise Value to Net Income | 36 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 0.65 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 16, 2026
EPS Estimate
$1.12
Average shareholder expectationRevenue Estimate
$10.96 B
Average shareholder expectationNext Earnings Call
Expected Date
October 21, 2026
EPS Estimate
$1.25
Average shareholder expectationRevenue Estimate
$11.47 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Abbott Laboratories
115,000 employees
CEO: Robert Ford Abbott Laboratories is a global healthcare company that discovers, develops, manufactures, and sells a wide range of health products through its subsidiaries worldwide. The company operates across four principal segments: Established Pha...